chr2_+_176987412
|
3.567
|
NM_014213
|
HOXD9
|
homeobox D9
|
chr4_-_186877869
|
3.507
|
NM_021069
|
SORBS2
|
sorbin and SH3 domain containing 2
|
chr3_-_112359962
|
3.417
|
NM_199511
NM_199512
|
CCDC80
|
coiled-coil domain containing 80
|
chr3_-_112359863
|
3.150
|
|
CCDC80
|
coiled-coil domain containing 80
|
chr17_+_70117168
|
3.088
|
|
SOX9
|
SRY (sex determining region Y)-box 9
|
chr3_-_112359660
|
2.965
|
|
CCDC80
|
coiled-coil domain containing 80
|
chr4_-_186733372
|
2.961
|
NM_003603
NM_001145670
|
SORBS2
|
sorbin and SH3 domain containing 2
|
chr1_+_220701800
|
2.959
|
|
MARK1
|
MAP/microtubule affinity-regulating kinase 1
|
chr7_-_113559048
|
2.845
|
NM_002711
|
PPP1R3A
|
protein phosphatase 1, regulatory subunit 3A
|
chr20_+_238376
|
2.771
|
NM_207469
|
DEFB132
|
defensin, beta 132
|
chr3_-_112359565
|
2.740
|
|
CCDC80
|
coiled-coil domain containing 80
|
chr5_+_15500288
|
2.688
|
NM_012304
|
FBXL7
|
F-box and leucine-rich repeat protein 7
|
chr11_+_34654010
|
2.626
|
NM_001206616
|
EHF
|
ets homologous factor
|
chr4_+_15471488
|
2.608
|
NM_001080522
NM_001164720
NM_020785
|
CC2D2A
|
coiled-coil and C2 domain containing 2A
|
chr11_+_111789600
|
2.605
|
NM_080659
|
C11orf52
|
chromosome 11 open reading frame 52
|
chr12_-_114843888
|
2.567
|
NM_181486
|
TBX5
|
T-box 5
|
chr17_-_56494930
|
2.439
|
NM_017763
|
RNF43
|
ring finger protein 43
|
chr6_-_46459710
|
2.437
|
NM_001251973
|
RCAN2
|
regulator of calcineurin 2
|
chr4_-_88450243
|
2.436
|
|
SPARCL1
|
SPARC-like 1 (hevin)
|
chr4_+_113739203
|
2.419
|
NM_001127493
|
ANK2
|
ankyrin 2, neuronal
|
chr3_-_112359547
|
2.418
|
|
CCDC80
|
coiled-coil domain containing 80
|
chr2_-_190044330
|
2.228
|
NM_000393
|
COL5A2
|
collagen, type V, alpha 2
|
chr19_+_46800296
|
2.224
|
NM_152795
|
HIF3A
|
hypoxia inducible factor 3, alpha subunit
|
chr3_-_133748828
|
2.175
|
NM_005630
|
SLCO2A1
|
solute carrier organic anion transporter family, member 2A1
|
chr4_+_119947816
|
2.153
|
|
SYNPO2
|
synaptopodin 2
|
chr17_+_41003360
|
2.126
|
|
|
|
chr9_+_686640
|
2.088
|
|
|
|
chr11_+_18287807
|
2.019
|
NM_000331
NM_001178006
NM_199161
|
SAA1
|
serum amyloid A1
|
chr17_-_9694613
|
1.972
|
NM_001105571
NM_001220493
|
DHRS7C
|
dehydrogenase/reductase (SDR family) member 7C
|
chr11_+_112046207
|
1.971
|
NM_031938
|
BCO2
|
beta-carotene oxygenase 2
|
chr12_-_8815479
|
1.970
|
|
MFAP5
|
microfibrillar associated protein 5
|
chr5_+_15500539
|
1.964
|
|
FBXL7
|
F-box and leucine-rich repeat protein 7
|
chr4_+_41540187
|
1.957
|
|
LIMCH1
|
LIM and calponin homology domains 1
|
chr12_-_15038724
|
1.953
|
NM_000900
NM_001190839
|
MGP
|
matrix Gla protein
|
chr7_-_27205123
|
1.910
|
|
HOXA9
|
homeobox A9
|
chr6_-_167040700
|
1.863
|
NM_021135
|
RPS6KA2
|
ribosomal protein S6 kinase, 90kDa, polypeptide 2
|
chrX_-_33146543
|
1.855
|
NM_004010
NM_004009
|
DMD
|
dystrophin
|
chr19_+_13080431
|
1.851
|
NM_152654
|
DAND5
|
DAN domain family, member 5
|
chr7_-_82073020
|
1.830
|
NM_000722
|
CACNA2D1
|
calcium channel, voltage-dependent, alpha 2/delta subunit 1
|
chr9_+_12693385
|
1.792
|
NM_000550
|
TYRP1
|
tyrosinase-related protein 1
|
chr4_-_186877413
|
1.758
|
|
SORBS2
|
sorbin and SH3 domain containing 2
|
chr10_-_125651494
|
1.687
|
NM_198148
|
CPXM2
|
carboxypeptidase X (M14 family), member 2
|
chr2_-_157189040
|
1.662
|
NM_006186
|
NR4A2
|
nuclear receptor subfamily 4, group A, member 2
|
chr18_-_24722757
|
1.661
|
NM_001243848
|
CHST9
|
carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 9
|
chr5_+_137203559
|
1.619
|
|
MYOT
|
myotilin
|
chr4_-_87028805
|
1.615
|
NM_138981
|
MAPK10
|
mitogen-activated protein kinase 10
|
chr17_+_70117177
|
1.596
|
|
SOX9
|
SRY (sex determining region Y)-box 9
|
chr14_+_96722546
|
1.565
|
NM_000710
|
BDKRB1
|
bradykinin receptor B1
|
chr7_-_27205148
|
1.562
|
NM_152739
|
HOXA9
|
homeobox A9
|
chr1_-_7973286
|
1.560
|
|
UTS2
|
urotensin 2
|
chr4_-_40936640
|
1.530
|
|
APBB2
|
amyloid beta (A4) precursor protein-binding, family B, member 2
|
chr9_-_104198045
|
1.510
|
NM_000035
|
ALDOB
|
aldolase B, fructose-bisphosphate
|
chr7_-_27205075
|
1.497
|
|
HOXA9
|
homeobox A9
|
chr4_-_186577858
|
1.472
|
|
SORBS2
|
sorbin and SH3 domain containing 2
|
chr8_+_62200524
|
1.449
|
NM_173519
|
CLVS1
|
clavesin 1
|
chr6_-_46293404
|
1.444
|
|
RCAN2
|
regulator of calcineurin 2
|
chr17_-_70116928
|
1.376
|
|
FLJ37644
|
uncharacterized LOC400618
|
chr1_-_242162364
|
1.376
|
NM_001004343
|
MAP1LC3C
|
microtubule-associated protein 1 light chain 3 gamma
|
chr2_+_177028804
|
1.362
|
NM_006898
|
HOXD3
|
homeobox D3
|
chr5_+_42756919
|
1.337
|
NM_001134848
|
CCDC152
|
coiled-coil domain containing 152
|
chrX_-_10588458
|
1.337
|
NM_000381
NM_033289
|
MID1
|
midline 1 (Opitz/BBB syndrome)
|
chr7_-_82072804
|
1.334
|
|
CACNA2D1
|
calcium channel, voltage-dependent, alpha 2/delta subunit 1
|
chr11_+_19372270
|
1.313
|
NM_001111018
|
NAV2
|
neuron navigator 2
|
chr1_-_204135420
|
1.311
|
NM_000537
|
REN
|
renin
|
chr18_+_32073245
|
1.299
|
NM_001198945
NM_001392
NM_032975
NM_032979
|
DTNA
|
dystrobrevin, alpha
|
chr5_+_137203544
|
1.282
|
NM_001135940
NM_006790
|
MYOT
|
myotilin
|
chr11_-_8892909
|
1.236
|
|
ST5
|
suppression of tumorigenicity 5
|
chr7_-_16505292
|
1.230
|
NM_015464
|
SOSTDC1
|
sclerostin domain containing 1
|
chr17_-_1619473
|
1.218
|
|
MIR22HG
|
MIR22 host gene (non-protein coding)
|
chr6_+_12290528
|
1.191
|
NM_001168319
NM_001955
|
EDN1
|
endothelin 1
|
chr5_+_102201526
|
1.185
|
NM_000919
NM_001177306
NM_138766
NM_138821
NM_138822
|
PAM
|
peptidylglycine alpha-amidating monooxygenase
|
chrX_+_99839789
|
1.179
|
NM_022144
|
TNMD
|
tenomodulin
|
chr1_+_61924621
|
1.176
|
|
NFIA
|
nuclear factor I/A
|
chr4_+_42399855
|
1.165
|
NM_001080505
|
SHISA3
|
shisa homolog 3 (Xenopus laevis)
|
chr6_-_138820578
|
1.144
|
NM_001144060
|
NHSL1
|
NHS-like 1
|
chr5_+_80529138
|
1.141
|
NM_001099735
NM_001099736
NM_001825
|
CKMT2
|
creatine kinase, mitochondrial 2 (sarcomeric)
|
chr10_+_71211316
|
1.138
|
|
|
|
chr16_+_56995761
|
1.137
|
NM_000078
|
CETP
|
cholesteryl ester transfer protein, plasma
|
chr3_-_158450271
|
1.120
|
NM_002888
NM_206963
|
RARRES1
|
retinoic acid receptor responder (tazarotene induced) 1
|
chr1_+_218518675
|
1.072
|
NM_001135599
NM_003238
|
TGFB2
|
transforming growth factor, beta 2
|
chr8_-_16050220
|
1.071
|
NM_002445
NM_138715
NM_138716
|
MSR1
|
macrophage scavenger receptor 1
|
chr9_+_137533643
|
1.012
|
NM_000093
|
COL5A1
|
collagen, type V, alpha 1
|
chr18_+_32073343
|
1.011
|
|
DTNA
|
dystrobrevin, alpha
|
chr2_+_219472618
|
0.996
|
|
PLCD4
|
phospholipase C, delta 4
|
chr15_+_91769329
|
0.993
|
|
SV2B
|
synaptic vesicle glycoprotein 2B
|
chr1_+_220701547
|
0.988
|
NM_018650
|
MARK1
|
MAP/microtubule affinity-regulating kinase 1
|
chr12_-_28124915
|
0.978
|
NM_002820
NM_198965
|
PTHLH
|
parathyroid hormone-like hormone
|
chrX_+_90689596
|
0.964
|
NM_080832
|
PABPC5
|
poly(A) binding protein, cytoplasmic 5
|
chr4_+_154125589
|
0.951
|
NM_015271
|
TRIM2
|
tripartite motif containing 2
|
chr9_+_1050333
|
0.944
|
NM_006557
NM_001130865
|
DMRT2
|
doublesex and mab-3 related transcription factor 2
|
chr2_-_51259536
|
0.941
|
NM_001135659
NM_004801
|
NRXN1
|
neurexin 1
|
chr12_-_8815266
|
0.940
|
|
MFAP5
|
microfibrillar associated protein 5
|
chr1_-_177939049
|
0.927
|
NM_033127
|
SEC16B
|
SEC16 homolog B (S. cerevisiae)
|
chr5_+_40909558
|
0.925
|
NM_000587
|
C7
|
complement component 7
|
chr2_+_62900985
|
0.909
|
NM_001142615
|
EHBP1
|
EH domain binding protein 1
|
chr4_-_76928601
|
0.889
|
NM_002416
|
CXCL9
|
chemokine (C-X-C motif) ligand 9
|
chr6_-_46293215
|
0.874
|
|
RCAN2
|
regulator of calcineurin 2
|
chr8_+_68864341
|
0.874
|
|
PREX2
|
phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 2
|
chrX_-_13835012
|
0.868
|
|
GPM6B
|
glycoprotein M6B
|
chr1_+_164528914
|
0.863
|
|
PBX1
|
pre-B-cell leukemia homeobox 1
|
chr8_-_124544376
|
0.858
|
NM_148177
|
FBXO32
|
F-box protein 32
|
chr17_-_79894967
|
0.855
|
NM_006907
NM_153824
|
PYCR1
|
pyrroline-5-carboxylate reductase 1
|
chr22_+_29449877
|
0.848
|
|
ZNRF3
|
zinc and ring finger 3
|
chr17_+_41003184
|
0.834
|
NM_003734
|
AOC3
|
amine oxidase, copper containing 3 (vascular adhesion protein 1)
|
chr13_-_78493902
|
0.826
|
NM_001201397
|
EDNRB
|
endothelin receptor type B
|
chr19_+_46801632
|
0.823
|
NM_022462
NM_152796
|
HIF3A
|
hypoxia inducible factor 3, alpha subunit
|
chr8_-_16050147
|
0.803
|
|
MSR1
|
macrophage scavenger receptor 1
|
chr4_+_77610610
|
0.802
|
|
SHROOM3
|
shroom family member 3
|
chr18_+_55712867
|
0.800
|
|
NEDD4L
|
neural precursor cell expressed, developmentally down-regulated 4-like
|
chr13_-_36429798
|
0.798
|
NM_001195415
NM_001195416
NM_001195430
|
DCLK1
|
doublecortin-like kinase 1
|
chr6_-_167040659
|
0.797
|
|
RPS6KA2
|
ribosomal protein S6 kinase, 90kDa, polypeptide 2
|
chr3_-_158450230
|
0.791
|
|
RARRES1
|
retinoic acid receptor responder (tazarotene induced) 1
|
chr5_+_40909487
|
0.790
|
|
C7
|
complement component 7
|
chr14_+_21510384
|
0.789
|
NM_032572
|
RNASE7
|
ribonuclease, RNase A family, 7
|
chr11_-_85397215
|
0.774
|
NM_152723
|
CCDC89
|
coiled-coil domain containing 89
|
chr3_-_64211111
|
0.773
|
NM_198859
|
PRICKLE2
|
prickle homolog 2 (Drosophila)
|
chr4_-_186578122
|
0.769
|
NM_001145674
NM_001145675
|
SORBS2
|
sorbin and SH3 domain containing 2
|
chr5_+_40909617
|
0.767
|
|
C7
|
complement component 7
|
chr11_-_68780667
|
0.757
|
NM_001098515
NM_145015
|
MRGPRF
|
MAS-related GPR, member F
|
chr4_-_100212085
|
0.757
|
NM_000667
|
ADH1A
|
alcohol dehydrogenase 1A (class I), alpha polypeptide
|
chr9_-_91793681
|
0.755
|
NM_016848
|
SHC3
|
SHC (Src homology 2 domain containing) transforming protein 3
|
chr17_-_37381920
|
0.748
|
NM_198993
|
STAC2
|
SH3 and cysteine rich domain 2
|
chr8_-_93029864
|
0.748
|
NM_175636
|
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related)
|
chr9_+_6215785
|
0.744
|
NM_001199640
NM_001199641
NM_033439
|
IL33
|
interleukin 33
|
chr4_+_41540320
|
0.742
|
|
LIMCH1
|
LIM and calponin homology domains 1
|
chr9_+_97521930
|
0.738
|
NM_001193329
|
C9orf3
|
chromosome 9 open reading frame 3
|
chr11_-_58499368
|
0.730
|
NM_005838
NM_201648
|
GLYAT
|
glycine-N-acyltransferase
|
chr4_+_110749149
|
0.720
|
NM_006583
|
RRH
|
retinal pigment epithelium-derived rhodopsin homolog
|
chr16_-_75301950
|
0.716
|
NM_001170715
|
BCAR1
|
breast cancer anti-estrogen resistance 1
|
chr1_+_61869699
|
0.705
|
|
NFIA
|
nuclear factor I/A
|
chr11_-_35278749
|
0.702
|
|
SLC1A2
|
solute carrier family 1 (glial high affinity glutamate transporter), member 2
|
chr5_-_146833150
|
0.695
|
NM_001387
|
DPYSL3
|
dihydropyrimidinase-like 3
|
chr3_-_158450205
|
0.692
|
|
RARRES1
|
retinoic acid receptor responder (tazarotene induced) 1
|
chr2_+_132285469
|
0.692
|
NM_138770
|
CCDC74A
|
coiled-coil domain containing 74A
|
chr8_-_13372183
|
0.691
|
NM_024767
NM_182643
|
DLC1
|
deleted in liver cancer 1
|
chr4_-_186300151
|
0.679
|
NM_018409
|
LRP2BP
|
LRP2 binding protein
|
chr22_+_38203899
|
0.673
|
NM_001171690
NM_014291
|
GCAT
|
glycine C-acetyltransferase
|
chr1_+_220701523
|
0.667
|
|
MARK1
|
MAP/microtubule affinity-regulating kinase 1
|
chr15_+_38544119
|
0.656
|
|
SPRED1
|
sprouty-related, EVH1 domain containing 1
|
chr7_+_89843133
|
0.655
|
NM_001040666
|
STEAP2
|
STEAP family member 2, metalloreductase
|
chr3_+_159557649
|
0.651
|
NM_001197109
|
SCHIP1
|
schwannomin interacting protein 1
|
chr2_+_219472631
|
0.647
|
|
PLCD4
|
phospholipase C, delta 4
|
chr10_-_113933517
|
0.646
|
|
GPAM
|
glycerol-3-phosphate acyltransferase, mitochondrial
|
chr7_-_37956515
|
0.646
|
NM_003014
|
SFRP4
|
secreted frizzled-related protein 4
|
chr18_-_24445652
|
0.645
|
NM_001650
|
AQP4
|
aquaporin 4
|
chr7_+_116451073
|
0.644
|
|
CAPZA2
|
capping protein (actin filament) muscle Z-line, alpha 2
|
chr21_-_31588242
|
0.643
|
NM_199328
|
CLDN8
|
claudin 8
|
chr3_+_119813600
|
0.640
|
|
|
|
chr10_+_71211215
|
0.637
|
NM_012339
|
TSPAN15
|
tetraspanin 15
|
chrX_+_100805415
|
0.637
|
NM_016608
|
ARMCX1
|
armadillo repeat containing, X-linked 1
|
chr11_-_64528186
|
0.635
|
NM_001164716
NM_005609
|
PYGM
|
phosphorylase, glycogen, muscle
|
chr12_-_54673879
|
0.633
|
|
CBX5
|
chromobox homolog 5
|
chr6_+_53883713
|
0.629
|
NM_138569
|
MLIP
|
muscular LMNA-interacting protein
|
chr21_-_27512668
|
0.628
|
NM_001136016
|
APP
|
amyloid beta (A4) precursor protein
|
chr21_+_35014624
|
0.625
|
NM_001001132
NM_003024
|
ITSN1
|
intersectin 1 (SH3 domain protein)
|
chr17_-_56494889
|
0.616
|
|
RNF43
|
ring finger protein 43
|
chr15_-_42448769
|
0.599
|
NM_213600
|
PLA2G4F
|
phospholipase A2, group IVF
|
chr3_+_159557745
|
0.599
|
|
SCHIP1
|
schwannomin interacting protein 1
|
chr19_+_14247974
|
0.598
|
|
LOC100507373
|
uncharacterized LOC100507373
|
chr20_+_56136136
|
0.583
|
NM_002591
|
PCK1
|
phosphoenolpyruvate carboxykinase 1 (soluble)
|
chr4_+_169418167
|
0.574
|
NM_001166108
NM_016081
|
PALLD
|
palladin, cytoskeletal associated protein
|
chr7_+_28448970
|
0.573
|
|
LOC401317
|
uncharacterized LOC401317
|
chr4_+_77610719
|
0.572
|
|
SHROOM3
|
shroom family member 3
|
chr1_-_8075678
|
0.564
|
|
ERRFI1
|
ERBB receptor feedback inhibitor 1
|
chr3_+_2280512
|
0.561
|
NM_001206955
|
CNTN4
|
contactin 4
|
chr4_+_6271558
|
0.556
|
NM_001145853
NM_006005
|
WFS1
|
Wolfram syndrome 1 (wolframin)
|
chr3_-_123339423
|
0.554
|
NM_053031
NM_053032
|
MYLK
|
myosin light chain kinase
|
chr1_-_163113938
|
0.553
|
|
RGS5
|
regulator of G-protein signaling 5
|
chr19_+_41103055
|
0.553
|
NM_001042544
|
LTBP4
|
latent transforming growth factor beta binding protein 4
|
chr11_+_22688156
|
0.552
|
NM_001143830
|
GAS2
|
growth arrest-specific 2
|
chr2_-_202507348
|
0.550
|
NM_152388
|
TMEM237
|
transmembrane protein 237
|
chr11_+_65266980
|
0.546
|
|
|
|
chr2_-_164592512
|
0.545
|
NM_018086
|
FIGN
|
fidgetin
|
chr11_+_75273245
|
0.540
|
|
SERPINH1
|
serpin peptidase inhibitor, clade H (heat shock protein 47), member 1, (collagen binding protein 1)
|
chr12_-_8815370
|
0.538
|
NM_003480
|
MFAP5
|
microfibrillar associated protein 5
|
chr5_+_140261792
|
0.537
|
NM_018904
NM_031865
|
PCDHA13
|
protocadherin alpha 13
|
chr7_+_116165089
|
0.537
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
chr21_-_47648715
|
0.536
|
NM_001001438
NM_001145436
NM_001145437
NM_002340
|
LSS
|
lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase)
|
chr3_+_158991035
|
0.535
|
NM_001197107
NM_001197108
NM_014575
|
SCHIP1
|
schwannomin interacting protein 1
|
chr11_+_34642651
|
0.531
|
|
EHF
|
ets homologous factor
|
chr18_+_21452981
|
0.529
|
NM_000227
NM_001127718
|
LAMA3
|
laminin, alpha 3
|
chr1_+_43766565
|
0.521
|
NM_001253357
NM_005424
|
TIE1
|
tyrosine kinase with immunoglobulin-like and EGF-like domains 1
|
chr20_-_44485953
|
0.515
|
NM_005469
|
ACOT8
|
acyl-CoA thioesterase 8
|
chr6_+_43738177
|
0.514
|
|
VEGFA
|
vascular endothelial growth factor A
|
chrX_+_77154956
|
0.512
|
NM_001866
|
COX7B
|
cytochrome c oxidase subunit VIIb
|
chr5_+_140729723
|
0.509
|
NM_018922
NM_032095
|
PCDHGB1
|
protocadherin gamma subfamily B, 1
|
chr12_-_6233684
|
0.508
|
NM_000552
|
VWF
|
von Willebrand factor
|
chr17_+_73720775
|
0.504
|
NM_001005619
|
ITGB4
|
integrin, beta 4
|
chr11_+_27062508
|
0.504
|
NM_003986
|
BBOX1
|
butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1
|
chr6_+_43738394
|
0.503
|
|
VEGFA
|
vascular endothelial growth factor A
|
chr11_-_62752370
|
0.503
|
NM_004790
NM_153276
NM_153277
NM_153278
|
SLC22A6
|
solute carrier family 22 (organic anion transporter), member 6
|
chrX_+_101975641
|
0.502
|
NM_001142524
NM_001142525
NM_001142526
NM_001142527
NM_001142528
NM_030639
|
BHLHB9
|
basic helix-loop-helix domain containing, class B, 9
|
chr4_+_6271588
|
0.502
|
|
WFS1
|
Wolfram syndrome 1 (wolframin)
|
chr12_-_371994
|
0.501
|
NM_001190997
NM_001243392
NM_016615
|
SLC6A13
|
solute carrier family 6 (neurotransmitter transporter, GABA), member 13
|
chr11_+_34642587
|
0.499
|
NM_001206615
NM_012153
|
EHF
|
ets homologous factor
|
chr21_+_47269874
|
0.499
|
NM_001130141
NM_020528
|
PCBP3
|
poly(rC) binding protein 3
|
chr6_-_116381765
|
0.490
|
NM_002031
|
FRK
|
fyn-related kinase
|
chr3_+_159943252
|
0.484
|
NM_001168214
|
C3orf80
|
chromosome 3 open reading frame 80
|
chr10_-_91403630
|
0.476
|
NM_138316
NM_148978
|
PANK1
|
pantothenate kinase 1
|
chr13_-_78493524
|
0.473
|
|
|
|